Guardant Health schedules Q3 2026 results for Nov. 5
Guardant Health will report third-quarter 2026 financial results after market close on Thursday, Nov. 5, with a webcast conference call at 1:30 p.m. PT.
--()--October 08, 2026- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. m. m.
Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: The webcast will be archived and available for replay after the event. About Guardant Health Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. com and follow the company on LinkedIn, X (Twitter) and Facebook. Source: Guardant Health, Inc. com (END) Dow Jones Newswires October 08, 2026 16:05 ET (20:05 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters.
Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.